Immunochina Competitors and Similar CompaniesClear all
Cullgen's competitors and similar companies include Divide & Conquer and Core Biogenesis.
 Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants. | |
Founding Date | Founding Date 2018 | Founding Date 2018 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Babraham, GB HQ | Locations Paris, FR HQ Illkirch Graffenstaden, FR |
Employees | Employees 4 | Employees 2 | Employees 293% decrease |
Funding | |||
Latest funding round | Latest funding round $ 16m (about 7 years ago) | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 11m (about 4 years ago) |
Total funding raised | Total funding raised $ 31m | Total funding raised $ 12.5m | Total funding raised $ 14.1m |
For sources of this data, please see the company profile
View Company Profiles
Divide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View companyCore Biogenesis
HQ
Paris, FR
Employees
29↓ 3% decrease
Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants.
View company